Unknown

Dataset Information

0

Oncology approvals in 2020: a year of firsts in the midst of a pandemic.

ABSTRACT:

SUBMITTER: Amiri-Kordestani L 

PROVIDER: S-EPMC7844812 | biostudies-literature | 2021 Mar

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Oncology approvals in 2020: a year of firsts in the midst of a pandemic.

Amiri-Kordestani Laleh L   Pazdur Richard R  

Nature reviews. Clinical oncology 20210301 3

Similar Datasets

Unknown Building biorepositories in the midst of a pandemic.
| S-EPMC8134891 | biostudies-literature
Unknown Prediction of drug approvals in oncology using explainable artificial intelligence.
| S-EPMC12808163 | biostudies-literature
Unknown Single-arm trials for domestic oncology drug approvals in China.
| S-EPMC10690876 | biostudies-literature
Unknown Medical education in the midst of pandemic and beyond.
| S-EPMC8014169 | biostudies-literature
Unknown European radiation oncology after one year of COVID-19 pandemic.
| S-EPMC8049845 | biostudies-literature
Unknown Real-World Evidence in Support of Oncology Product Registration: A Systematic Review of New Drug Application and Biologics License Application Approvals from 2015-2020.
| S-EPMC9401526 | biostudies-literature
Unknown Liquidity-poor Households in the Midst of the COVID-19 Pandemic.
| S-EPMC9115429 | biostudies-literature
Unknown Locking out prevention: Dental care in the midst of a pandemic.
| S-EPMC9350414 | biostudies-literature
Unknown The eHealth usage during COVID-19 pandemic 2020 year–Case of Poland
| S-EPMC10473534 | biostudies-literature
Unknown In the Midst of a Pandemic, Introverts May Have a Mortality Advantage.
| S-EPMC9164451 | biostudies-literature